Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$5.02 - $21.06
Next Earnings Date
May 01 2025
Next Earnings Date
May 01 2025
Latest price
Market Cap | $3.51B |
EV | $3.41B |
Shares Outstanding | 194.94M |
Beta | 1.32 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $17.78 |
P/E 2025E | - |
P/Revenue 2025E | 0.94x |
Revenue | 32.30% |
EPS | 12.60% |
Operating Cash Flow | - |
Free Cash Flow | 7.80% |
Revenue | 28.80% |
EPS | - |
Operating Cash Flow | 76.80% |
Free Cash Flow | - |
Gross Margin 2025E | 11.51% |
Net Profit Margin 2025E | -1.83% |
ROE 2025E | -65.14% |
ROCE 2024 | -99.72% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Alignment Healthcare, Inc.
ALHC
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Kao, John
Employees
1,679
Website
www.alignmenthealth.comIPO Date
2021-03-26
Headquarters
1100 West Town and Country Road, Suite 1600, Orange, California, 92868, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved